Kathleen M Sakamoto

Title: Kathleen M Sakamoto: Innovator in Targeted Ubiquitination

Introduction

Kathleen M Sakamoto is a prominent inventor based in Manhattan Beach, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the area of targeted ubiquitination. With a total of 2 patents, her work has the potential to impact various therapeutic applications.

Latest Patents

Sakamoto's latest patents focus on the development of proteolysis targeting chimeric pharmaceuticals. These inventions are based on the discovery of a composition that provides targeted ubiquitination. Specifically, the composition contains a ubiquitin pathway protein binding moiety that recognizes a ubiquitin pathway protein and a targeting moiety that recognizes a target protein. Additionally, the invention provides libraries of compositions, where each composition contains a ubiquitin pathway protein binding moiety and a member of a molecular library. These libraries can be utilized to identify proteins involved in predetermined cellular functions.

Career Highlights

Throughout her career, Kathleen M Sakamoto has worked with esteemed institutions such as the California Institute of Technology and Yale University. Her research has been instrumental in advancing the understanding of protein interactions and their implications in cellular processes.

Collaborations

Sakamoto has collaborated with notable colleagues, including Craig M Crews and Raymond J Dashaies. These partnerships have further enriched her research and contributed to her innovative work in the field.

Conclusion

Kathleen M Sakamoto's contributions to the field of pharmaceuticals through her innovative patents in targeted ubiquitination highlight her role as a leading inventor. Her work continues to pave the way for advancements in therapeutic applications.